Transgene Biotek Board Meeting on 13th Nov'26 for Q2 Financial Results
Transgene Biotek Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Transgene Biotek Board Meeting on 13th Nov'26 for Q2 Financial Results Transgene Biotek Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the standalone and consolidated un-audited financial results and limited review report for the quarter and half-year ended 30th Sep'26. The board will also evaluate the re-appointment of Dr. K. Koteswara Rao as Chairman and Managing Director for a one-year term, subject to shareholder approval. Additionally, the board will finalize the notice, Board鈥檚 Report, record date, book closure, and e-voting schedule for the 36th Annual General Meeting.
Original exchange filing (PDF)
More announcements from Transgene Biotek Ltd
- CUT OFF DATE 路 13 Nov 2026
- Unaudited Financial Results 路 13 Nov 2026
- 1) Unaudited Financial Results: Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended 30th September, .... 路 13 Nov 2026
- 1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS: The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish Gummadi & Co., Chartered .... 路 04 Nov 2026
- Intimation of Resignation of Statutory of Auditors - M/S. Harish Gummadi & Co.., Chartered Accountants. 路 04 Nov 2026
- 1. APPOINTMENT OF STATUTORY AUDITORS TO FILL THE CASUAL VACANCY: The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment of M/s. Harish .... 路 02 Nov 2026
- Submission of Additional Details Pursuant to BSE Observation -Resignation of Statutory Auditors under Regulation 30 of SEBI (LODR) Regulations, 2015. 路 01 Nov 2026
- Submission of Additional Details pursuant to BSE Observation -Resignation of Statutory Auditors under Regulation 30 of SEBI (LODR) Regulation, 2015. 路 01 Nov 2026
